Wells Fargo analyst Christopher Manuel believes the 8% selloff yesterday in shares of Berry Global Group creates a "dislocation" and attractive entry point. The company is well positioned to deliver $700M-plus of free cash flow in fiscal 2019, Manuel tells investors in a research note. While Berry is facing near-term inflationary headwinds across most of its business, the company is out aggressively implementing non-material price increases as well as activity managing the business to preserve its low-cost supplier position, the analyst contends. He keeps an Outperform rating on the shares with a slightly reduced $69 price target.

Berry Global (BERY) and Glatfelter (GLT) announced the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry's Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business, or HHNF, with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino, or HSR, Antitrust Improvements Act. As previously announced on February 7, Berry and Glatfelter entered into a definitive agreement under which Berry will spin-off and merge its HHNF business with Glatfelter in a Reverse Morris Trust transaction. The transaction will create a leading, publicly-traded company in the specialty materials industry. The transaction is expected to close in the second half of calendar 2024 and is subject to approval by Glatfelter shareholders and completion of customary closing conditions.